The GJB2 gene, associated with the condition involving knuckle pads, leukonychia (white nails), and sensorineural deafness, is the focus of a specialized genetic test available at DNA Labs UAE. This comprehensive analysis is designed to identify mutations in the GJB2 gene, which can indicate a predisposition to these specific physical manifestations along with hearing impairment. Sensorineural deafness is a type of hearing loss resulting from damage to the inner ear or to the nerve pathways from the inner ear to the brain, often having genetic roots. The presence of knuckle pads (thickened skin over the knuckles) and leukonychia further points towards a unique genetic syndrome linked to the GJB2 gene.
Understanding the genetic underpinning of these conditions can be crucial for early intervention, management strategies, and providing a clear diagnosis for affected individuals. The test, priced at 4400 AED, is a significant step towards personalized medicine, allowing for tailored approaches to treatment and care based on one's genetic makeup. Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients are assured of accurate, reliable results and comprehensive support through their diagnostic journey.
The COL11A1 Gene Marshall Syndrome Genetic Test is a specific diagnostic tool used to identify mutations in the COL11A1 gene, which is known to be associated with Marshall Syndrome. Marshall Syndrome is a rare genetic disorder characterized by a spectrum of symptoms including distinctive facial features, eye abnormalities, hearing loss, and skeletal anomalies. The test plays a crucial role in the early detection and management of the condition, enabling healthcare providers to offer personalized treatment plans and genetic counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test ensures high accuracy and reliability. The test cost is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the specialized expertise required to interpret the results. By choosing DNA Labs UAE for the COL11A1 Gene Marshall Syndrome Genetic Test, patients can expect state-of-the-art services, confidentiality, and support throughout the testing process.
The TRMU Gene Mitochondrial Modifier of Deafness Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the TRMU gene, which have been associated with non-syndromic hearing loss and sensitivity to aminoglycoside antibiotics. This test plays a crucial role in understanding the genetic basis of hearing impairment in individuals and can be pivotal in guiding treatment and management decisions, especially in avoiding medications that could potentially exacerbate the condition. Priced at 4400 AED, this test offers a valuable tool for individuals and families seeking insights into the genetic underpinnings of deafness, enabling them to make informed healthcare decisions.
The TIMM8A gene opticoacoustic nerve atrophy with dementia genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the TIMM8A gene. These mutations are associated with a rare genetic disorder that impacts the optic and acoustic nerves, leading to vision and hearing loss, alongside cognitive decline manifesting as dementia. The condition, also known as Mohr-Tranebjaerg syndrome, is inherited in an X-linked recessive pattern, meaning it predominantly affects males.
The test involves a comprehensive analysis of the patient's DNA to identify any abnormalities in the TIMM8A gene that could lead to the disorder. Early detection through this genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling to affected families.
At DNA Labs UAE, the cost of the TIMM8A gene opticoacoustic nerve atrophy with dementia genetic test is set at 4400 AED. This fee covers the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a detailed report of the findings. The report not only offers insights into the patient's genetic condition but also guides healthcare providers in tailoring personalized treatment and management plans for the patient.
The FLNA Gene Otopalatodigital Syndrome Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the FLNA gene, which are linked to the development of Otopalatodigital Syndrome Type 1 (OPD1). This rare genetic disorder is characterized by skeletal abnormalities, facial dysmorphisms, hearing loss, and in some cases, heart and kidney problems. The FLNA gene plays a crucial role in cell structure and signaling, and mutations in this gene can disrupt normal development and function.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is 4400 AED, which reflects the comprehensive analysis involved in identifying the specific genetic mutation associated with OPD1. This test is crucial for families seeking to understand the genetic basis of the condition, potentially aiding in early intervention, management strategies, and genetic counseling. By pinpointing the exact mutation in the FLNA gene, healthcare providers can offer more personalized care and support to affected individuals and their families.
The FLNA Gene Otopalatodigital Syndrome Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FLNA gene, which are linked to Otopalatodigital Syndrome Type 2 (OPD2). OPD2 is a rare genetic disorder characterized by skeletal abnormalities, distinctive facial features, and possible intellectual disabilities. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can disrupt normal skeletal development.
This test is crucial for individuals showing symptoms of OPD2 or those with a family history of the condition, as it provides a definitive diagnosis by identifying specific genetic alterations in the FLNA gene. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations associated with the syndrome.
The cost of the FLNA Gene Otopalatodigital Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its importance in the accurate diagnosis and management of OPD2, the investment is invaluable for affected families. Early diagnosis through genetic testing can lead to better management of the syndrome's symptoms and improved quality of life for those affected.
The SLC26A4 gene is associated with Pendred syndrome, a genetic disorder that affects the inner ear and thyroid gland, leading to hearing loss and a goiter. The condition is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene—one from each parent—are required for a person to be affected. The SLC26A4 gene plays a crucial role in the development and function of the inner ear and thyroid, and mutations in this gene can disrupt these processes.
To diagnose Pendred syndrome, a genetic test targeting the SLC26A4 gene can be conducted. This test involves analyzing the DNA to identify mutations in the SLC26A4 gene that are known to cause the condition. It is a critical tool for confirming the diagnosis, understanding the risk of passing the condition to future generations, and managing the treatment plan effectively.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test for Pendred syndrome. The cost of the test is 4400 AED. By opting for this test at DNA Labs UAE, individuals suspected of having Pendred syndrome or those with a family history of the condition can gain valuable insights into their genetic makeup. The results from this test can help in making informed decisions regarding health and family planning.
The FLCN Gene Pneumothorax Primary Spontaneous Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FLCN gene, which are associated with an increased risk of developing primary spontaneous pneumothorax (PSP). PSP is a condition characterized by the sudden onset of a collapsed lung without any apparent cause, which can lead to severe respiratory issues and requires immediate medical attention. The FLCN gene plays a crucial role in the regulation of cell growth and division, and mutations in this gene can disrupt normal lung tissue integrity, leading to PSP.
This genetic test is a valuable tool for individuals who have a family history of PSP or have experienced spontaneous pneumothorax themselves, as it can help in assessing their risk of developing the condition. Early detection of FLCN gene mutations allows for proactive monitoring and management of potential lung complications, significantly improving the quality of life for individuals at risk.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and personalized care provided with the service. Undergoing this test at DNA Labs UAE ensures access to state-of-the-art genetic testing technologies, expert interpretation of test results, and guidance on the next steps for individuals found to carry FLCN gene mutations.
The DNAI1 gene primary ciliary dyskinesia type 1 genetic test is a specialized diagnostic tool designed to identify mutations in the DNAI1 gene, which are associated with primary ciliary dyskinesia (PCD) type 1. This condition is a rare, genetic disorder that affects the cilia, leading to issues with respiratory function, fertility, and sometimes, organ laterality. Identifying mutations in the DNAI1 gene can confirm a diagnosis of PCD type 1, allowing for appropriate management and treatment strategies to be implemented.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in a laboratory setting. DNA Labs UAE offers this genetic test, providing a reliable service for diagnosing PCD type 1. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted in a state-of-the-art facility, the test is an important resource for individuals presenting symptoms of PCD or those with a family history of the condition, enabling early intervention and personalized care plans.
The DNAAF2 gene, associated with Primary Ciliary Dyskinesia (PCD) Type 10, plays a crucial role in the proper functioning of cilia, which are tiny hair-like structures that line the respiratory tract, reproductive system, and other parts of the body. Mutations in the DNAAF2 gene disrupt cilia function, leading to a variety of symptoms including chronic respiratory infections, fertility issues, and situs inversus in some cases.
To diagnose this specific type of PCD, genetic testing for mutations in the DNAAF2 gene is available. At DNA Labs UAE, individuals suspected of having PCD Type 10 can undergo this genetic test. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for the presence of mutations in the DNAAF2 gene.
The cost of the DNAAF2 gene test at DNA Labs UAE is 4400 AED. This investment can provide crucial information for the diagnosis and management of PCD Type 10, enabling targeted treatments and interventions that can significantly improve the quality of life for affected individuals.
